LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing <i>LOXL2</i>-induced epithelial-mesenchymal transition (EMT)
Ting Peng, Shitong Lin, Yifan Meng, Peipei Gao, Ping Wu, Ping Wu, Wenhua Zhi, Wencheng Ding, Canhui Cao, Peng Wu, Peng Wu
Abstract
median inhibitory concentration; PPI protein-protein interaction.
Topics & Concepts
Lysyl oxidaseEpithelial–mesenchymal transitionCancer researchCarcinogenesisBiologyExtracellular matrixCervical cancerCancerMetastasisCell biologyGeneticsMicrobial metabolism and enzyme functionMathematical Biology Tumor GrowthMacrophage Migration Inhibitory Factor